Imidazole Antimicrobial via Ionic Liquid Catalysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a growing need for new antimicrobial agents effective against drug-resistant microorganisms, particularly bacteria and fungi, due to increasing antibiotic resistance, and existing methods for synthesizing organic compounds often require environmentally harmful solvents and inefficient processes.
Innovation Solution
The synthesis of 4,5-bis(4-bromophenyl)-1-hexyl-2-(3,4-dimethoxyphenyl)-1H-imidazole via a one-pot four-component reaction using pyridinium hydrogen sulfate as a catalyst and green solvent, demonstrating excellent antimicrobial activity against gram-positive and gram-negative bacteria, as well as fungi.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional solvents are used for synthesizing organic compounds, then the synthesis process can proceed efficiently, but it causes environmental pollution and VOC emissions
Solution Approach 1:
The patent changes the physical and chemical parameters of the reaction system by replacing conventional volatile organic solvents with ionic liquids. This substitution maintains the reaction efficiency while eliminating VOC emissions and environmental pollution, as ionic liquids have negligible vapor pressure and can be reused multiple times
Solution Approach 2:
The patent introduces ionic liquids as intermediary substances that serve dual functions: as green solvents for the synthesis reaction and as reusable catalysts. The ionic liquid mediates the reaction between the starting materials to produce the imidazole derivative while maintaining environmental friendliness and process efficiency
2Manufacturing precision
If traditional multi-step synthesis methods are used for imidazole derivatives, then each step can be optimized independently, but the overall process becomes complex and time-consuming
Solution Approach 1:
The patent merges multiple synthesis steps into a single one-pot four-component reaction. All four starting materials (aldehyde, ketone, ammonium salt, and nitrogen source) are combined in one reaction vessel with ionic liquid catalyst to directly produce the imidazole derivative, eliminating the need for sequential isolation and purification steps
Solution Approach 2:
The ionic liquid catalyst serves multiple functions simultaneously: it acts as a solvent, catalyst, and reaction medium for the one-pot synthesis. This multi-functionality simplifies the overall process by eliminating the need for separate optimization of multiple reaction conditions
3Reliability
If existing antimicrobial agents are used, then treatment protocols are established, but increasing antibiotic resistance reduces their effectiveness
Solution Approach 1:
The patent changes the chemical structure parameters by introducing bromophenyl and dimethoxyphenyl substituents on the imidazole core, creating a novel compound with new molecular properties. This structural modification confers activity against drug-resistant microorganisms while maintaining reliability against susceptible strains
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compound exhibits high antimicrobial activity against Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, and Candida albicans, offering a promising therapeutic option while utilizing environmentally friendly synthesis methods.
Implementation Method 1
pyridinium hydrogen sulfate as a catalyst
Data Source
AI summary
An 4,5-bis(4-bromophenyl)-1-hexyl-2-(3,4-dimethoxyphenyl)-1H-imidazole compound, its synthesis, and its use as an antimicrobial agent.